2005•Journal of Molecular MedicineOpen access

An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells

Sergia Bortolanza, Cheng Qian, Maria Gabriela Kramer, Celia Gomar, Jesús Prìeto, Fabio Farinati, Rubén Hernández-Alcoceba

Open full text 17 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Oncolytic adenovirus, Oncolytic virus, Telomerase, Telomerase reverse transcriptase, Cancer cell, Biology, Cell culture, Molecular biology

Back to paper search Browse research topics Original source

An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells — Research Paper | ScholarLens